Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Table of Contents

July 2012; Volume 32,Issue 7

Special Issue on New Anticancer Agents

  • You have access
    Novel Approaches in the Pharmacotherapy of Skeletal-related Events in Metastatic Castrate-resistant Prostate Cancer
    SHAWN SPENCER, BERNARD L. MARINI and WILLIAM D. FIGG
    Anticancer Research July 2012, 32 (7) 2391-2398;
  • You have access
    Efficacy of Sequential Treatment with Sunitinib-Everolimus in an Orthotopic Mouse Model of Renal Cell Carcinoma
    JAMES LARKIN, NORBERT ESSER, EMILIANO CALVO, ZENTA TSUCHIHASHI, ULRIKE FIEDLER, RALPH GRAESER and DENNIS KIM
    Anticancer Research July 2012, 32 (7) 2399-2406;
  • You have access
    Synergistic Killing of Glioblastoma Stem-like Cells by Bortezomib and HDAC Inhibitors
    THOMAS ASKLUND, SAMUEL KVARNBRINK, CAMILLA HOLMLUND, CARL WIBOM, TOMMY BERGENHEIM, ROGER HENRIKSSON and HÅKAN HEDMAN
    Anticancer Research July 2012, 32 (7) 2407-2413;
  • You have access
    Effects of (5Z)-7-Oxozeaenol on MDA-MB-231 Breast Cancer Cells
    ULYANA MUÑOZ ACUÑA, JENNIFER WITTWER, SLOAN AYERS, CEDRIC J. PEARCE, NICHOLAS H. OBERLIES and ESPERANZA J. CARCACHE DE BLANCO
    Anticancer Research July 2012, 32 (7) 2415-2421;
  • You have access
    Asparaginases: Biochemical Pharmacology and Modes of Drug Resistance
    VASSILIOS I. AVRAMIS
    Anticancer Research July 2012, 32 (7) 2423-2437;
  • You have access
    New Anticancer Immunotherapies
    HESTER A. FRANKS, QUNWEI WANG and POULAM M. PATEL
    Anticancer Research July 2012, 32 (7) 2439-2453;
  • You have access
    Silibinin Inhibits Tumor Growth in a Murine Orthotopic Hepatocarcinoma Model and Activates the TRAIL Apoptotic Signaling Pathway
    SOUAD BOUSSEROUEL, GAETAN BOUR, HENRIETTE KAUNTZ, FRANCINE GOSSÉ, JACQUES MARESCAUX and FRANCIS RAUL
    Anticancer Research July 2012, 32 (7) 2455-2462;
  • You have access
    PI3 Kinase Inhibitors in the Clinic: An Update
    JEAN-EMMANUEL KURTZ and ISABELLE RAY-COQUARD
    Anticancer Research July 2012, 32 (7) 2463-2470;
  • You have access
    Therapeutic Potential of Tranilast, an Anti-allergy Drug, in Proliferative Disorders
    MOSHE ROGOSNITZKY, RACHEL DANKS and ELENA KARDASH
    Anticancer Research July 2012, 32 (7) 2471-2478;
  • You have access
    siRNA-Mediated Down-regulation of Ceramide Synthase 1 Leads to Apoptotic Resistance in Human Head and Neck Squamous Carcinoma Cells after Photodynamic Therapy
    DUSKA SEPAROVIC, PAUL BREEN, NICHOLAS JOSEPH, JACEK BIELAWSKI, JASON S. PIERCE, ERIC VAN BUREN and TATYANA I. GUDZ
    Anticancer Research July 2012, 32 (7) 2479-2485;
  • You have access
    Novel Radiosensitizing Anticancer Therapeutics
    AMANDA G. LINKOUS and EUGENIA M. YAZLOVITSKAYA
    Anticancer Research July 2012, 32 (7) 2487-2499;
  • You have access
    Determination of the Optimal Route of Administration of Salmonella typhimurium A1-R to Target Breast Cancer in Nude Mice
    YONG ZHANG, YASUNORI TOME, ATSUSHI SUETSUGU, LEI ZHANG, NAN ZHANG, ROBERT M. HOFFMAN and MING ZHAO
    Anticancer Research July 2012, 32 (7) 2501-2508;
  • You have access
    Real-time Imaging of Apoptosis Induction of Human Breast Cancer Cells by the Traditional Chinese Medicinal Herb Tubeimu
    MINGXIN HU, MING ZHAO, CHAO AN, MENG YANG, QUANWANG LI, YONG ZHANG, ATSUSHI SUETSUGU, YASUNORI TOME, SHUYA YANO, YANLING FU, ROBERT M. HOFFMAN and KAIWEN HU
    Anticancer Research July 2012, 32 (7) 2509-2514;
  • You have access
    New Anticancer Agents: Hormones Made within the Heart
    DAVID L. VESELY
    Anticancer Research July 2012, 32 (7) 2515-2521;
  • You have access
    Anti-breast Cancer Effects of Histone Deacetylase Inhibitors and Calpain Inhibitor
    MEGAN A. MATAGA, SHOSHANA ROSENTHAL, SARAH HEERBOTH, AMRITA DEVALAPALLI, SHANNON KOKOLUS, LEAH R. EVANS, MCKENNA LONGACRE, GENEVIEVE HOUSMAN and SIBAJI SARKAR
    Anticancer Research July 2012, 32 (7) 2523-2529;
  • You have access
    The Role of PI3K/mTOR Inhibition in Combination with Sorafenib in Hepatocellular Carcinoma Treatment
    ROBERTO GEDALY, PAUL ANGULO, CHANGGUO CHEN, KATE TOWNSEND CREASY, BRETT T. SPEAR, JONATHAN HUNDLEY, MICHAEL F. DAILY, MALAY SHAH and B. MARK EVERS
    Anticancer Research July 2012, 32 (7) 2531-2536;
  • You have access
    Impact of Yangzheng Xiaoji on the Adhesion and Migration of Human Cancer Cells: the Role of the AKT Signalling Pathway
    LIN YE, KE JI, NATASHA FREWER, JIAFU JI and WEN G JIANG
    Anticancer Research July 2012, 32 (7) 2537-2543;
  • You have access
    Preventive Effect of Traditional Japanese Medicine on Neurotoxicity of FOLFOX for Metastatic Colorectal Cancer: A Multicenter Retrospective Study
    AYUMU HOSOKAWA, KOHEI OGAWA, TAKAYUKI ANDO, NOBUHIRO SUZUKI, AKIRA UEDA, SHINYA KAJIURA, YUKA KOBAYASHI, YUJI TSUKIOKA, NAOKI HORIKAWA, KAZUHISA YABUSHITA, JUNYA FUKUOKA and TOSHIRO SUGIYAMA
    Anticancer Research July 2012, 32 (7) 2545-2550;
  • You have access
    Targeting HSP90 by the Novel Inhibitor NVP-AUY922 Reduces Growth and Angiogenesis of Pancreatic Cancer
    CHRISTIAN MOSER, SVEN A. LANG, CHRISTINA HACKL, CHRISTINE WAGNER, EVA SCHEIFFERT, HANS J. SCHLITT, EDWARD K. GEISSLER and OLIVER STOELTZING
    Anticancer Research July 2012, 32 (7) 2551-2561;
  • You have access
    Highly Efficient Cationic Ethylphosphatidylcholine siRNA Carrier for GFP Suppression in Modified Breast Cancer Cells
    BORIS TENCHOV, YASURO SUGIMOTO, RUMIANA KOYNOVA, ROBERT W. BRUEGGEMEIER and ROBERT J. LEE
    Anticancer Research July 2012, 32 (7) 2563-2566;
  • You have access
    Death by Design: Where Curcumin Sensitizes Drug-resistant Tumours
    SHILPI SAHA, ARGHYA ADHIKARY, PUSHPAK BHATTACHARYYA, TANYA DAS and GAURISANKAR SA
    Anticancer Research July 2012, 32 (7) 2567-2584;
  • You have access
    A Significant Role of Lipogenic Enzymes in Colorectal Cancer
    MARIA NOTARNICOLA, CATERINA MESSA and MARIA GABRIELLA CARUSO
    Anticancer Research July 2012, 32 (7) 2585-2590;
  • You have access
    New Therapeutic Agents in Uveal Melanoma
    T.R. VELHO, E. KAPITEIJN and M.J. JAGER
    Anticancer Research July 2012, 32 (7) 2591-2598;
  • You have access
    Tumor Cell-protective Catalase as a Novel Target for Rational Therapeutic Approaches Based on Specific Intercellular ROS Signaling
    GEORG BAUER
    Anticancer Research July 2012, 32 (7) 2599-2624;
  • You have access
    The Root Bark of Paeonia moutan is a Potential Anticancer Agent in Human Oral Squamous Cell Carcinoma Cells
    CHUNNAN LI, KAZUNAGA YAZAWA, SEIJI KONDO, YOSHIKI MUKUDAI, DAISUKE SATO, YUJI KURIHARA, TAKAAKI KAMATANI and SATORU SHINTANI
    Anticancer Research July 2012, 32 (7) 2625-2630;
  • You have access
    Protein-bound Polysaccharide-K (PSK) Induces Apoptosis via p38 Mitogen-activated Protein Kinase Pathway in Promyelomonocytic Leukemia HL-60 Cells
    NORIYUKI HIRAHARA, TAKEO EDAMATSU, AYAKO FUJIEDA, MASAKI FUJIOKA, TSUTOMU WADA and YOSHITSUGU TAJIMA
    Anticancer Research July 2012, 32 (7) 2631-2637;
  • You have access
    Synergistic Inhibition of HTLV-1-infected Cell Proliferation by Combination of Cepharanthine and a Tetramethylnaphthalene Derivative
    MASAAKI TOYAMA, TAKAYUKI HAMASAKI, TOMOFUMI UTO, HIROSHI AOYAMA, MIKA OKAMOTO, YUICHI HASHMOTO and MASANORI BABA
    Anticancer Research July 2012, 32 (7) 2639-2645;
  • You have access
    Delta-tocotrienol Augments Cisplatin-induced Suppression of Non-small Cell Lung Cancer Cells via Inhibition of the Notch-1 Pathway
    XIANGMING JI, ZHIWEI WANG, FAZLUL H. SARKAR and SMITI V. GUPTA
    Anticancer Research July 2012, 32 (7) 2647-2655;
  • You have access
    Macro- and Microdistributions of Boron Drug for Boron Neutron Capture Therapy in an Animal Model
    YU-CHUAN LIN, JENG-JONG HWANG, SHYH-JEN WANG, BANG-HUNG YANG, CHI-WEI CHANG, MING-CHEN HSIAO and FONG-IN CHOU
    Anticancer Research July 2012, 32 (7) 2657-2664;
  • You have access
    Effects of (5Z)-7-Oxozeaenol on the Oxidative Pathway of Cancer Cells
    ULYANA MUÑOZ ACUÑA, JENNIFER WITTWER, SLOAN AYERS, CEDRIC J. PEARCE, NICHOLAS H. OBERLIES and ESPERANZA J. CARCACHE DE BLANCO
    Anticancer Research July 2012, 32 (7) 2665-2671;
  • You have access
    Apoptotic Effects of Resveratrol, a Grape Polyphenol, on Imatinib-Sensitive and Resistant K562 Chronic Myeloid Leukemia Cells
    GEYLANI CAN, ZEYNEP CAKIR, MELIS KARTAL, UFUK GUNDUZ and YUSUF BARAN
    Anticancer Research July 2012, 32 (7) 2673-2678;
  • You have access
    Enhancement of Cisplatin Cytotoxicity by Disulfiram Involves Activating Transcription Factor 3
    ANNA O'BRIEN, JANET E.B. BARBER, STEPHANIE REID, NIMA NIKNEJAD and JIM DIMITROULAKOS
    Anticancer Research July 2012, 32 (7) 2679-2688;
  • You have access
    Effects of Zeng Sheng Ping/ACAPHA on Malignant Brain Tumor Growth and Notch Signaling
    KAH JING LIM, KDA RAJAN and CHARLES G. EBERHART
    Anticancer Research July 2012, 32 (7) 2689-2696;
  • You have access
    Superior Cytotoxicity of Hydrophylic Gold Carboxylato Complexes Over Hydrophylic Silver Carboxylates
    ERNST H.G. LANGNER, JANNIE C. SWARTS, ANDRÉ TUCHSCHERER, HEINRICH LANG, GISELA K. JOONE and CONSTANCE E.J. VAN RENSBURG
    Anticancer Research July 2012, 32 (7) 2697-2701;
  • You have access
    Blood Vessel Normalization in the Hamster Oral Cancer Model for Experimental Cancer Therapy Studies
    ANA J. MOLINARI, ROMINA F. AROMANDO, MARIA E. ITOIZ, MARCELA A. GARABALINO, ANDREA MONTI HUGHES, ELISA M. HEBER, EMILIANO C.C. POZZI, DAVID W. NIGG, VERÓNICA A. TRIVILLIN and AMANDA E. SCHWINT
    Anticancer Research July 2012, 32 (7) 2703-2709;
  • You have access
    Structural Requirements for Mitotane Activity: Development of Analogs for Treatment of Adrenal Cancer
    DAVID E. SCHTEINGART, JOSEPH E. SINSHEIMER, RICARDO S. BENITEZ, DOMINIC F. HOMAN, TIMOTHY D. JOHNSON and RAYMOND E. COUNSELL
    Anticancer Research July 2012, 32 (7) 2711-2720;
  • You have access
    Cytotoxic Effects of N'-Formyl-2-(5-nitrothiophen-2-yl) benzothiazole-6-carbohydrazide in Human Breast Tumor Cells by Induction of Oxidative Stress
    JUAN R. RODRIGUES, JAIME CHARRIS, JOSÉ CAMACHO, ARTHUR BARAZARTE, NEIRA GAMBOA and FERNANDO ANTUNES
    Anticancer Research July 2012, 32 (7) 2721-2726;
  • You have access
    Anticancer Effects of Eleven Triterpenoids Derived from Antrodia camphorata
    YI-PANG LEE, WAN-CHI TSAI, CHIH-JAN KO, YERRA KOTESWARA RAO, CHIUNG-RU YANG, DAR-REN CHEN, MING-HUI YANG, CHI-CHIANG YANG and YEW-MIN TZENG
    Anticancer Research July 2012, 32 (7) 2727-2734;
  • You have access
    In Vitro and In Vivo Anticancer Effects of Destruxin B on Human Colorectal Cancer
    YI-PANG LEE, CHE-WEI WANG, WAN-CHUN LIAO, CHIUNG-RU YANG, CHI-TAI YEH, CHUNG-HUNG TSAI, CHI-CHIANG YANG and YEW-MIN TZENG
    Anticancer Research July 2012, 32 (7) 2735-2745;
  • You have access
    Role of Melatonin in Cancer Treatment
    ANTONIO CUTANDO, ANTONIO LÓPEZ-VALVERDE, SALVADOR ARIAS-SANTIAGO, JOAQUIN DE VICENTE and RAFAEL GÓMEZ DE DIEGO
    Anticancer Research July 2012, 32 (7) 2747-2753;
  • You have access
    New Frontiers for Astrocytic Tumours
    ROSANNA NANO, ALESSANDRO LASCIALFARI, MAURIZIO CORTI, ALESSANDRO PAOLINI, FRANCESCA PASI, FRANCO CORBELLA and RICCARDO DI LIBERTO
    Anticancer Research July 2012, 32 (7) 2755-2758;
  • You have access
    SIVmac239-Nef Down-regulates Cell Surface Expression of CXCR4 in Tumor Cells and Inhibits Proliferation, Migration and Angiogenesis
    CHENGZHONG CAI, FIONA R. RODEPETER, ANNETTE ROSSMANN, AFSHIN TEYMOORTASH, JIN-SEOK LEE, KARL QUINT, PIETRO DI FAZIO, MATTHIAS OCKER, JOCHEN A. WERNER and ROBERT MANDIC
    Anticancer Research July 2012, 32 (7) 2759-2768;
  • You have access
    Combination of Three Metals for the Treatment of Cancer: Gallium, Rhenium and Platinum. 1. Determination of the Optimal Schedule of Treatment
    PHILIPPE COLLERY, AHMED MOHSEN, ANTHONY KERMAGORET, JEAN D'ANGELO, GEORGES MORGANT, DIDIER DESMAELE, ALAIN TOMAS, THOMAS COLLERY, MING WEI and ABDELFATTAH BADAWI
    Anticancer Research July 2012, 32 (7) 2769-2781;
  • You have access
    Mafosfamide as a New Anticancer Agent: Preclinical Investigations and Clinical Trials
    LIDIA MAZUR, MAŁGORZATA OPYDO-CHANEK, MARTA STOJAK and KATARZYNA WOJCIESZEK
    Anticancer Research July 2012, 32 (7) 2783-2789;
  • You have access
    Effect of Histone Deacetylase Inhibitors Trichostatin A and Valproic Acid on Etoposide-induced Apoptosis in Leukemia Cells
    EWA JASEK, GRZEGORZ J. LIS, MAŁGORZATA JASIŃSKA, HALINA JURKOWSKA and JAN A. LITWIN
    Anticancer Research July 2012, 32 (7) 2791-2799;
  • You have access
    The Anticancer Effect of 2’-3’-dehydrosalannol on Triple-negative Breast Cancer Cells
    THIYAGARAJAN BOOPALAN, ARUNKUMAR ARUMUGAM, CHENDIL DAMODARAN and LAKSHMANASWAMY RAJKUMAR
    Anticancer Research July 2012, 32 (7) 2801-2806;
  • You have access
    Efficacy of Combination Chemotherapy Using Oral Fluoropyrimidine S-1 with Oxaliplatin (SOX) against Colorectal Cancer In Vivo
    MAMORU NUKATSUKA, HITOSHI SAITO, KAZUKI SAKAMOTO, FUMIO NAKAGAWA, JUNJI UCHIDA, TAKASHI KOBUNAI, KAZUYOSHI SHIRAISHI and TEIJI TAKECHI
    Anticancer Research July 2012, 32 (7) 2807-2812;
  • You have access
    Effect of BMP4 on the Growth and Clonogenicity of Human Leukemia and Lymphoma Cells
    YUSUKE TAKAHASHI, TOMOHIRO ISHIGAKI, YUKI OKUHASHI, AYA ONO, MAI ITOH, NOBUO NARA and SHUJI TOHDA
    Anticancer Research July 2012, 32 (7) 2813-2817;
  • You have access
    Relationship between Structure and Antiproliferative Activity of 1-Azaflavanones
    SATORU KAWAII, KOTARO ENDO, TETSUO TOKIWANO and YUKO YOSHIZAWA
    Anticancer Research July 2012, 32 (7) 2819-2825;
  • You have access
    Esophageal Cancer Exhibits Resistance to a Novel IGF-1R Inhibitor NVP-AEW541 with Maintained RAS-MAPK Activity
    XIAO-HONG BAO, MUNENORI TAKAOKA, HUI-FANG HAO, ZHI-GANG WANG, TAKUYA FUKAZAWA, TOMOKI YAMATSUJI, KAZUFUMI SAKURAMA, DONG-SHENG SUN, TAKESHI NAGASAKA, TOSHIYOSHI FUJIWARA and YOSHIO NAOMOTO
    Anticancer Research July 2012, 32 (7) 2827-2834;
  • You have access
    MicroRNA-21 Inhibition Enhances In Vitro Chemosensitivity of Temozolomide-resistant Glioblastoma Cells
    STANLEY THIAN SZE WONG, XIAO-QIN ZHANG, JAMES TIN-FONG ZHUANG, HIN-LUN CHAN, CHI-HAN LI and GILBERTO KA KIT LEUNG
    Anticancer Research July 2012, 32 (7) 2835-2841;
  • You have access
    Anticancer Activity of a Quercetin-based Polymer Towards HeLa Cancer Cells
    FRANCESCO PUOCI, CATIA MORELLI, GIUSEPPE CIRILLO, MANUELA CURCIO, ORTENSIA ILARIA PARISI, PAMELA MARIS, DIEGO SISCI and NEVIO PICCI
    Anticancer Research July 2012, 32 (7) 2843-2847;
  • You have access
    Effects of Docetaxel, Doxorubicin and Cyclophosphamide on Human Breast Cancer Cell Line MCF-7
    MARIANNA TREBUNOVA, GALINA LAPUTKOVA, EVA SLABA, KAMILA LACJAKOVA and ANETA VEREBOVA
    Anticancer Research July 2012, 32 (7) 2849-2854;
  • You have access
    Anti-invasive Effects and Proapoptotic Activity Induction by the Rexinoid IIF and Valproic Acid in Combination on Colon Cancer Cell Lines
    A. PAPI, A.M. FERRERI, F. GUERRA and M. ORLANDI
    Anticancer Research July 2012, 32 (7) 2855-2862;
  • You have access
    In Vitro Cytotoxic Activity of Novel Protoflavone Analogs – Selectivity Towards a Multidrug Resistant Cancer Cell Line
    B. DANKO, A. MARTINS, D.W. CHUANG, H.C. WANG, L. AMARAL, J. MOLNÁR, F.R. CHANG, Y.C. WU and A. HUNYADI
    Anticancer Research July 2012, 32 (7) 2863-2869;
  • You have access
    The Organic Arsenic Derivative GMZ27 Induces PML–RARα-Independent Apoptosis in Myeloid Leukemia Cells
    XIAODONG CHENG, ALFONSO QUINTÁS-CARDAMA, MIRNA GOLEMOVIC, RALPH ZINGARO, MING-ZHANG GAO, EMIL J. FREIREICH, MICHAEL ANDREEFF, HAGOP M. KANTARJIAN and SRDAN VERSTOVSEK
    Anticancer Research July 2012, 32 (7) 2871-2880;
  • You have access
    Comparative Chemosensitivity of Circulating Human Prostate Cancer Cells and Primary Cancer Cells
    RHIANA MENEN, MING ZHAO, LEI ZHANG, MOHAMED K. HASSANEIN, VLADIMER BOBEK, KATARINA KOLOSTOVA, MICHAEL BOUVET and ROBERT M. HOFFMAN
    Anticancer Research July 2012, 32 (7) 2881-2884;
  • You have access
    Enalapril-induced Apoptosis of Acute Promyelocytic Leukaemia Cells Involves STAT5A
    OZLEM PURCLUTEPE, GUNIZ ISKENDER, HATICE DEMET KIPER, BURCIN TEZCANLI, NUR SELVI, CIGIR BIRAY AVCI, BUKET KOSOVA, AYSUN ADAN GOKBULUT, FAHRI SAHIN, YUSUF BARAN and GURAY SAYDAM
    Anticancer Research July 2012, 32 (7) 2885-2893;
  • You have access
    Inhibition of Invasion and Migration by Newly Synthesized Quinazolinone MJ-29 in Human Oral Cancer CAL 27 Cells through Suppression of MMP-2/9 Expression and Combined Down-regulation of MAPK and AKT Signaling
    CHI-CHENG LU, JAI-SING YANG, JO-HUA CHIANG, MANN-JEN HOUR, SAKAE AMAGAYA, KUNG-WEN LU, JING-PIN LIN, NOU-YING TANG, TSUNG-HAN LEE and JING-GUNG CHUNG
    Anticancer Research July 2012, 32 (7) 2895-2903;
  • You have access
    (−)-Epicatechin Enhances Etoposide-induced Antileukaemic Effect in Rats with Acute Myeloid Leukaemia
    MONIKA A. PAPIEŻ, KAROLINA BUKOWSKA-STRAKOVÁ, WIRGINIA KRZYŚCIAK and JAROSŁAW BARAN
    Anticancer Research July 2012, 32 (7) 2905-2913;
  • You have access
    Cytotoxicity of Ruthenocene-containing β-Diketones
    K. CHRISTIAN KEMP, MARGO J. NELL, CONSTANCE E.J. VAN RENSBURG and JANNIE C. SWARTS
    Anticancer Research July 2012, 32 (7) 2915-2918;
  • You have access
    Novel Liposomal Gefitinib (L-GEF) Formulations
    XIAOJU ZHOU, BRYANT YUNG, YIFEI HUANG, HONG LI, XIANMING HU, GUANGYA XIANG and ROBERT J. LEE
    Anticancer Research July 2012, 32 (7) 2919-2923;
  • You have access
    Cytotoxicity and Type of Cell Death Induced by Local Anesthetics in Human Oral Normal and Tumor cells
    KATSUE KOBAYASHI, SEIKA OHNO, SHIGENORI UCHIDA, OSAMU AMANO, HIROSHI SAKAGAMI and HIROSHI NAGASAKA
    Anticancer Research July 2012, 32 (7) 2925-2933;
  • You have access
    New Molecularly Targeted Therapies for Glioblastoma Multiforme
    JIRI POLIVKA, JIRI POLIVKA, VLADIMIR ROHAN, ONDREJ TOPOLCAN and JIRI FERDA
    Anticancer Research July 2012, 32 (7) 2935-2946;
  • You have access
    Inhibitors of Bacterial Efflux Pumps that also Inhibit Efflux Pumps of Cancer Cells
    LEONARD AMARAL, GABRIELLA SPENGLER, ANA MARTINS, ANA ARMADA, JADWIGA HANDZLIK, KATARZYNA KIEC-KONONOWICZ and JOSEPH MOLNAR
    Anticancer Research July 2012, 32 (7) 2947-2957;
  • You have access
    Oxazolinodoxorubicin – a Promising New Anthracycline
    MALGORZATA LUKAWSKA, DAGMARA KLOPOTOWSKA, MAGDALENA MILCZAREK, JOANNA WIETRZYK, KAZIMIERZ STUDZIAN, LESZEK SZMIGIERO, ANNA POREBSKA and IRENA OSZCZAPOWICZ
    Anticancer Research July 2012, 32 (7) 2959-2965;
  • You have access
    TRAIL and Taurolidine Enhance the Anticancer Activity of Doxorubicin, Trabectedin and Mafosfamide in HT1080 Human Fibrosarcoma Cells
    K. HARATI, A.M. CHROMIK, D. BULUT, O. GOERTZ, S. HAHN, T. HIRSCH, L. KLEIN-HITPASS, M. LEHNHARDT, W. UHL and A. DAIGELER
    Anticancer Research July 2012, 32 (7) 2967-2984;
  • You have access
    Fiber-substituted Conditionally Replicating Adenovirus for Oncolysis of Human Renal Carcinoma Cells
    HISAO NAGAYA, MASATOSHI TAGAWA, KAZUHIRO HIWASA, SHUJI TERAO, TAKESHI KANNO, TOMOYUKI NISHIZAKI and AKINOBU GOTOH
    Anticancer Research July 2012, 32 (7) 2985-2989;
  • You have access
    The Potential of RECK Inducers as Antitumor Agents for Glioma
    YUN CHEN and SHENG-HONG TSENG
    Anticancer Research July 2012, 32 (7) 2991-2998;
  • You have access
    New Anticancer Agents: Recent Developments in Tumor Therapy
    RIYASAT ALI, ZEENAT MIRZA, GHULAM M.D. ASHRAF, MOHAMMAD AMJAD KAMAL, SHAKEEL AHMED ANSARI, GHAZI ABDULLAH DAMANHOURI, ADEL MOHAMMAD ABUZENADAH, ADEEL GA CHAUDHARY and ISHFAQ AHMED SHEIKH
    Anticancer Research July 2012, 32 (7) 2999-3005;
  • You have access
    LXR Agonists and ABCG1-dependent Cholesterol Efflux in MCF-7 Breast Cancer Cells: Relation to Proliferation and Apoptosis
    ALI EL ROZ, JEAN-MARIE BARD, JEAN-MICHEL HUVELIN and HASSAN NAZIH
    Anticancer Research July 2012, 32 (7) 3007-3013;
Back to top
PreviousNext

In this issue

Anticancer Research
Vol. 32, Issue 7
July 2012
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
Entire Issue ($200)
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire